South Korea to start talks on COVID-19 drug remdesivir purchases

South Korea said it will begin talks with Gilead Sciences to purchase stocks of remdesivir, one of the first drugs shown to be effective against COVID-19, after the company agreed to allocate nearly all of its supply to the U.S. over the next three months.


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram: